Your cart

There are no items in your shopping cart

DCZ0415

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 3216

CAS [2242470-43-3]

MF C23H20N2O2
MW 356.42

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

DCZ0415

Description

DCZ0415 is an AAA-ATPase TRIP13 inhibitor with a Kd value of 2.42 μM. DCZ0415 induced antimyeloma activity in vitro (IC50 values of 1.0-10 μM in multiple myeloma cell lines), in vivo, and in primary cells derived from drug-resistant patients with myeloma. Moreover, DCZ0415 impaired nonhomologous end joining repair and inhibited NF-κB activity.

KEYWORDS: DCZ0415 | supplier | TRIP13 inhibitor | DCZ 0415 | DCZ-0415 | CAS [2242470-43-3] | ATP | ATPase (AAA+) | Inhibitor | Enzymes | Multiple myeloma

Order
Size Unit Price Stock
5 mg €85.00 In Stock
25 mg €290.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €140.00 In Stock
2 x 25 mg €500.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
2663 Rbin-1 Potent, reversible, and specific inhibitor of Midasin €125.00
2712 Rbin-2 Potent, reversible, and specific inhibitor of Midasin €95.00
3581 ONC212 TRAIL inducer; Selective GPR132 agonist €110.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...